Skip to main content

United States News All stories

Every story in this section, newest first — page 218 of 373.

Grafa
Technology

AMC Robotics achieves adjusted profitability in 2025 as NovaArm™ commercialization nears

AMC Robotics (NASDAQ:AMCI) today reported its financial results for the full year ended December 31, 2025, marking a transition point as the company nears the commercial rollout of its core technology suite.

Read more: AMC Robotics achieves adjusted profitability in 2025 as NovaArm™ commercialization nears
Grafa

FDA grants priority review to Merck’s Keytruda combo for muscle-invasive bladder cancer

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) involving its anti-PD-1 therapy, Keytruda.

Read more: FDA grants priority review to Merck’s Keytruda combo for muscle-invasive bladder cancer
Grafa

FDA grants priority review to Pfizer and Astellas for Padcev-Keytruda combo in MIBC

Pfizer (NYSE:PFE) and Astellas announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for the perioperative use of Padcev (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab).

Read more: FDA grants priority review to Pfizer and Astellas for Padcev-Keytruda combo in MIBC